Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep256 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Influence of diabetes mellitus on changes in preperitoneal fat measured by nutritional ultrasound, in a cohort of patients who required intensive care unit (ICU) admittance due to severe covid-19 pneumonia, during a 6-month follow-up program

Simon Frapolli Victor Jose , Aguilar Isabel Vegas , Rosa Victoria Gonzalez , Sanchez Garcia Ana Maria , Tinahones Madueno Francisco Jose , Garcia Almeida Jose Manuel

Introduction and Objectives: Preperitoneal fat is an ectopic visceral adipose tissue with a significant proinflammatory metabolic impact. The objective of this study is to measure preperitoneal fat by nutritional ultrasound at discharge, 3 months and 6 months in a cohort of patients who required admission to the Intensive Care Unit (ICU) due to severe COVID-19 pneumonia, and to analyze the differences based on the presence or not of previous DM.Material ...

ea0090ep599 | Endocrine-related Cancer | ECE2023

Treatment with 177Lu-dotatate in metastasic advanced neuroendocrine tumors with positive expression of somatostatin receptors, in a third level hospital in Spain from 2015–2022

Giron Giselle , Hernandez Lorena , ISABEL DEL OLMO GARCIA MARIA , Camara-Gomez Rosa , Bello Pilar , Prado Stephan , Segura Angel , Francisco Merino Torres Juan

Introduction: 177Lu-Oxodotreotide(PRRT-Lu) has the approval by EMA and FDA since 2017 for the treatment of patients with gastro-entero-pancreatic neuroendocrine tumors(GEP-NET). However, in daily clinical practice it has also been used in other NET tumors such as paragangliomas, lung NET, medullary thyroid cancer, and others. The aim of this study is to describe the characteristics and follow-up of patients treated with PRRT-Lu in a third level hospital in Spain fro...

ea0090ep672 | Pituitary and Neuroendocrinology | ECE2023

Early Left Ventricular Diastolic Dysfunction in Females with Chronic Hyperprolactinemia: a Doppler Echocardiographic Study

Marra Alberto Maria , Arcopinto Michele , D'Assante Roberta , Valente Valeria , Simona Auriemma Renata , Crisci Giulia , Giardino Federica , Pirchio Rosa , Pivonello Rosario , Bossone Eduardo , Colao Annamaria , Cittadini Antonio

Despite the myocardial prolactin (PRL) binding activity and the known effect to enhance contractility in the isolated rat heart, little information is available concerning the cardiovascular consequences of hyperprolactinemia in humans. To elucidate the effects of chronic hyperprolactinemia on cardiac structure and function, twenty-four patients with isolated PRL-secreting adenoma and twenty-four controls underwent a complete mono- and two-dimensional Doppler echocardiography....

ea0090ep727 | Pituitary and Neuroendocrinology | ECE2023

Prolactin-secreting pituitary adenoma: Clinical, radiological features and predictors of response to dopamine agonists

Romanisio Martina , Ferrero Alice , Daffara Tommaso , Catenazzi Sara , Pitino Rosa , Cavigiolo Beatrice , Zavattaro Marco , Marzullo Paolo , Caputo Marina , Prodam Flavia , Aimaretti Gianluca

Aim: Prolactinomas are the most frequent pituitary adenomas. Clear predictors of response to dopamine agonists (DA) are still discussed. The purpose of the study was to evaluate the clinical, radiological and hormonal characteristics of PRL-secreting pituitary adenomas, and to evaluate morphological changes over time and predictors of response to DA.Patients and Methods: Patients affected by PRL-secreting adenoma undergoing DA therapy in follow-up in a t...

ea0090ep1108 | Late Breaking | ECE2023

Utility of nutritional ultrasound for body composition in patients affected by obesity and overweight. Utility of nutritional ultrasound for body composition in patients affected by obesity and overweight

Tozzi Rossella , Garcia Delgado Yaiza , Maria Sanchez Hernandez Rosa , Gil Quintana Yaiza , Hernandez Hernandez Diego , Davila Veronica , Boronat Mauro , Mariani Stefania , Gnessi Lucio , Maria Claudia Wagner Anna

Background and aim: Dual energy X-ray absorptiometry (DXA) is considered the gold standard to evaluate BC, even if it requires the use of radiations, an expensive equipment and cannot be performed at the patientÂ’s bedside. Nutritional ultrasound (NU) evaluates BC through the assessment of muscle mass and the abdominal subcutaneous (superficial and deep-layer) and visceral adipose tissue. We aimed at comparing the accuracy and reliability of this emerging tool with DXA in ...

ea0063gp234 | Anterior and Posterior Pituitary | ECE2019

Is the molecular study of pituitary transcription factors useful in the identification of Pituitary Neuroendocrine Tumor subtypes according to the new WHO 2017 criteria?

Garcia-Martinez Araceli , Martinez-Lopez Sebastian , Torregrosa Maria Eugenia , Silva Sandra , Fajardo Carmen , Camara Rosa , Lamas Cristina , Aranda Ignacio , Pico Antonio

Introduction: Recently we have demonstrated the contribution of the quantification of expression of adenohypophyseal hormone genes in the identification of the different Pituitary Neuroendocrine Tumor (PitNET) subtypes according to the 2004 WHO criteria.Aim: The aim of the present study was to evaluate the contribution of the quantification of expression of pituitary transcription factor genes to the identification of PitNETs according to 2017 WHO criter...

ea0063p264 | Pituitary and Neuroendocrinology 1 | ECE2019

β-arrestin 2 expression is required for dopamine receptor type 2 (DRD2) inhibitory effects on Akt phosphorylation and cell proliferation in PRL-secreting and non functioning pituitary tumors

Mangili Federica , Giardino Elena , Treppiedi Donatella , Catalano Rosa , Locatelli Marco , Lania Andrea G , Spada Anna , Arosio Maura , Mantovani Giovanna , Peverelli Erika

Dopamine receptor type 2 (DRD2) agonists (DAs) are the first-choice treatment for PRL-secreting pituitary tumors due to their efficacy in reducing tumor size and hormonal secretion. However, DAs are poorly effective in non-functioning pituitary tumors (NFPTs), despite most of them express DRD2. No correlation between DAs clinical responsiveness and DRD2 expression was found, suggesting post-receptor alterations underlying resistance. DRD2 signaling pathways that control cell p...

ea0063p405 | Thyroid 1 | ECE2019

Radiofrequency ablation in the treatment of benign thyroid nodules: a good alternative to surgery

Moreno Cristina , Paja Miguel , Izuzquiza Ana , Espiga Javier , Arrizabalaga Cristina , Martinez Adela Leyre , Monzon Andoni , Zabala Rosa , Iglesias Natalia , Calles Laura

Introduction: To date, benign thyroid nodules complainig of symptomatic or cosmetic problems and autonomous functioning thyroid nodules (AFTN) have generally been treated with surgery or I131. Radiofrequency ablation (RFA) is a novel technique that has demonstrated safety and efficacy in the treatment of these nodules. We describe the clinical experience at our hospital.Material and method: We include 33 patients (28 women, 5 men) from January 2013 to Se...

ea0063p581 | Diabetes, Obesity and Metabolism 2 | ECE2019

Flash glucose monitoring: repercussions in glycemic control

Rebollo-Roman Angel , Alhambra-Exposito Maria-Rosa , Moreno-Moreno Paloma , Alcantara-Laguna Maria , Leon-Idougourram Soraya , Palomares-Ortega Rafael , Galvez-Moreno Maria-Angeles

Introduction: Flash glucose monitoring (FGM) allows non-invasive glucose level assessment. Studies have shown that patients using FGM test their glucose levels more often than those who use traditional blood glucose testing. Given that a higher rate of glucose testing has showed to improve glycemic control our objective was to describe the change in the glycemic control and time in euglycemic range in patients with FGM and the effect of the number of scans in this control....

ea0063p712 | Pituitary and Neuroendocrinology 2 | ECE2019

Does silent pituitary neuroendocrine tumors show lower specific adenohypophyseal gene hormone expression than functioning ones?

Torregrosa Maria Eugenia , Garcia-Martinez Araceli , Lopez-Munoz Beatriz , Sanchez-Barbie Angel , Camara Rosa , Lamas Cristina , Fajardo Carmen , Serrano Sol , Pico Antonio

Introduction: Pituitary Neuroendocrine Tumor (PitNET) subtypes present functioning and silent variants but the silencing mechanisms are still unknown. One of the possible hypotheses could be a decrease in the expression of the specific adenohypophyseal hormone genes. The aim of the present study was to analyze the expression of adenohypophyseal hormone genes in a series of PitNETs, in order to evaluate differences between functioning and silent PitNET subtypes, taking into acc...